Should risky treatments be reserved for secondary prevention? Theoretical considerations regarding risk-benefit tradeoffs.
Westover MB, Eiseman NA, Bianchi MT. Should risky treatments be reserved for secondary prevention? Theoretical considerations regarding risk-benefit tradeoffs. J Clin Epidemiol. 2012 Aug; 65(8):877-86.